Malignant primary cardiac sarcomas are usually located in the right atrium of the heart and are most commonly angiosarcomas.The malignant primary cardiac tumors are often diagnosed in young patientswho have a poor prognosis and survival rate of only 10% According to the WHO, the prevalence of melanoma skin cancers has been increasing from the past few decades.Furthermore, 132,000 melanoma skin cancers cases are reported each year across the globe.A small percentage of cardiac tumor cases are hereditary, the tumors can also be associated with another health condition, such as LAMB Syndrome, Carney Syndrome or NAME Syndrome.They result from cell overgrowth but mostly cardiac tumors results from metastatic condition, where cells from other cancerous organ such as lung and breast, soft-tissues and metastasizes to the heart.The Global Heart Tumor Market is expected to grow at a CAGR of approximately 7.1% during the forecast period 2017-2023.Heart Tumor Market Key PlayersSome of key the players in the Global heart tumor market are Tomtec Imaging Systems GmBh, Koninklijke Philips N.V., Siemens Healthineers, Circle Cardiovascular Imaging Inc., Toshiba Corporation, Shimadzu Corporation, CardioComm Solutions Inc., Integer Holdings Corporation, Pie Medical Imaging, HeartSciences, 3mensio Medical Imaging, and eMedica, S.L.Heart Tumor Market SegmentationThe heart tumor is segmented on the basis of type, diagnosis, treatment.On the basis of the type, the market is segmented into primary tumors and secondary tumors.The metastatic secondary tumors are divided into hematogenic and lymphatic and the contiguity is sub categorized into mediastinal tumors, lung tumors and oesophageal, or cardia tumor.On the basis of the diagnosis, the market is classified into echocardiogram, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), radionuclide imaging, Position Emission Tomography (PET) Scan, myocardial biopsy, cardiac catherization, and electrophysiology test.On the basis of the treatment, the market is classified into surgery, chemotherapy, radiation therapy.Furthermore, the surgery is further categorized into open heart surgery, minimal invasive surgery, and heart transplant surgery International Heart Tumor Market Regional AnalysisThe global heart tumor market consists of four major regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.
PITTSBURGH--Carnegie Mellon University's Assistant Professor of Electrical and Computer Engineering (ECE) Maysam Chamanzar and ECE Ph.D. student Matteo Giuseppe Scopelliti today published research that introduces a novel technique which uses ultrasound to noninvasively take optical images through a turbid medium such as biological tissue to image body's organs.In other words: one day, scopes may no longer need to be inserted into the body, such as down the throat or under the skin, to reach the stomach, brain, or any other organs for examination.Endoscopic imagers, or cameras on the end of catheter tubes or wires, are usually implanted through a medical procedure or surgery in order to reach the body's deep tissues, but Chamanzar's new technique provides a completely non-surgical and noninvasive alternative.The lab's paper published in Light: Science and Applications, a journal published by Springer Nature, shows that they can use ultrasound to create a virtual "lens" within the body, rather than implanting a physical lens.By using ultrasonic wave patterns, the researchers can effectively "focus" light within the tissue, which allows them to take images never before accessible through noninvasive means.Chamanzar's lab, however, has used noninvasive ultrasound to induce more transparency to enable more penetration of light through turbid media, such as biological tissue.
The global Hadron Therapy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.The objectives of this study are to define, segment, and project the size of the Hadron Therapy market based on company, product type, end user and key regions.Radiation therapy is the medical use of ionizing radiation to treat cancer.In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells.With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago.The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators.Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications.
University of Rhode Island chemical engineering assistant professor Daniel Roxbury plans to use carbon nanotubes, which are 100,000 times smaller than the width of a human hair, to serve as sensors and gather information for biomedical purposes.The funding was awarded to Roxbury through NSF's Faculty Early Career Development Program (CAREER).They can function as sensors by changing the color of the light that is emitted in response to a detected molecule.We will use this technique to count the number of nanotube sensors that enter the cells."The researchers will first investigate the behavior of nanotubes in simple solutions and biological fluids (blood plasma) before moving on to live cells.Once the research team is ready to examine the interactions of nanotubes with a variety of live human cells, they will conduct experiments using immune cells, cancer cells and cells that line the blood vessels.
On the other hand, the more mammograms a woman has, the more likely it is she will see a false positive result.After 10 years of annual mammograms, roughly two out of three patients who do not have cancer will be told that they do and be subjected to an invasive intervention, most likely a biopsy.Breast ultrasound elastography is an emerging imaging technique that provides information about a potential breast lesion by evaluating its stiffness in a non-invasive way.Assad Oberai, USC Viterbi School of Engineering Hughes Professor in the Department of Aerospace and Mechanical Engineering, asked this exact question in the research paper, "Circumventing the solution of inverse problems in mechanics through deep learning: application to elasticity imaging," published in Computer Methods in Applied Mechanics and Engineering.Along with a team of researchers, including USC Viterbi Ph.D student Dhruv Patel, Oberai specifically considered the following: Can you train a machine to interpret real-world images using synthetic data and streamline the steps to diagnosis?In the research, Oberai sought to determine if they could skip the most complicated steps of this workflow entirely.
BROOKLYN, New York, Thursday, July 11, 2019 - Theodore (Ted) S. Rappaport, a New York University professor and founding director of the research center NYU WIRELESS, is the recipient of the 2020 Eric E. Sumner Award from the Institute of Electrical and Electronics Engineers (IEEE), which cited his pioneering research in the field of wireless telecommunications.Rappaport's groundbreaking research in radio wave propagation, wireless communication system design, and broadband wireless communications circuits and systems, including work at millimeter wave (mmWave) frequencies (30 to 300 gigahertz), paved the way for several generations of wireless technology and sparked the commercialization of fifth-generation (5G) wireless technology.Before Rappaport published his seminal 2013 paper, "Millimeter Wave Mobile Communications for 5G Cellular: It Will Work," in an IEEE journal, few experts acknowledged the possibilities of tapping that underutilized spectrum.Now, NYU WIRELESS, which Rappaport launched upon arriving at the NYU Tandon School of Engineering in 2012, is moving well beyond 5G research.With other NYU WIRELESS researchers, he is exploring THz for ultra-fast, high-capacity data transmission and revolutionary applications for communications, medical imaging, precise position location, semiconductor testing, and new kinds of spectroscopy."Ted Rappaport has been a linchpin in making NYU a world leader in the field of wireless communications, as well as an educator who has inspired and nurtured the next generation of innovators in the field," said NYU Tandon Dean Jelena Kovačevi?.
The various types of Medical imaging are radiology, X-ray radiography, medical-ultrasound, fluoroscopy, mammography, endoscopy, elastography, tactile imaging, magnetic resonance imaging, thermography, positron emission tomography, photon emission computed tomography, and nuclear medicine imaging.How does Medical Imaging help?The images of the human body parts or organs are created using a variety of means such as ultrasound, magnetic resonance, nuclear medicine, and X-rays to allow physicians to see deep inside the body and identify the medical problems.In case of, diagnosis and treatment of cancer, medical imaging has proved to be particularly life-saving.Similar to that of an ultrasound, medical imaging helps doctors to examine the internal body structures of an unborn child such as muscles, tendons, vessels, joints, and internal organs.The ultrasounds are conducted during the second trimester of pregnancy to get an image of the unborn baby in the womb.
We are in the early stages of deep learning, which has quickly evolved thanks to recent advancements in machine learning (ML), computer vision (CV), and artificial intelligence (AI).What makes deep learning unique from traditional forms of ML is that these systems require massive amounts of data, are incredibly good at finding patterns, and can scale.Data scientists start by getting data, cleaning it, tagging it, and writing code to “train” a model.During the process, data scientists may go through hundreds of experiments.So what happens when something goes wrong, or when you need to validate the results of a past experiment against a new version?Already, organizations like the FDA are proposing regulatory frameworks to help standardize and validate the use of AI and ML geared explicitly towards medical devices.
NASA has announced it will be contracting with SpaceX to launch its newest X-Ray observatory into space.This is the sixth contract the company has won through NASA’s Lunch Service Program, which oversees the launch of unmanned rockets carrying satellites for scientific missions by contracting commercial companies.The estimated cost of the launch is $50.3 million, making it a relatively cheap project by NASA standards.One reason that SpaceX was chosen as the contractor for the launch is that it offered the use of a large Falcon 9 rocket for a lower price than other companies’ smaller rockets.The observatory will be launched aboard a Falcon 9 from Launch Complex 39A in Florida, and liftoff is planned for April 2021.“SpaceX is honored that NASA continues to place its trust in our proven launch vehicles to deliver important science payloads to orbit,” Gwynne Shotwell, president and chief operating officer of SpaceX, said in a statement.
C-Arms is medical imaging device that is based on X-ray technology and can be used flexibly.The name is derived from the C-shaped arm used to connect the X-ray source and X-ray detector to one another.C-arm is a device that has radiographic capabilities and is used in imaging for various applications such as critical care, surgical, orthopedic, and emergency care procedures.C-arms is a precise and accurate device that reduces patient discomforting in various types of surgical and non-surgical procedures.Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-634A C-arm is different from other imaging devices that are used for diagnosis commonly such as ultrasounds, traditional X-rays and MRIs.The C-arm produces real-time images for intraoperative (during surgery) applications, allowing physicians to see into a patient’s anatomy, making procedures less invasive and more effective.C-Arms Devices Market: Drivers and Restraints Presently, C-arm devices global market is driven by the technological advancement in healthcare industry, by aging population, and increasing prevalence of osteoporosis disease.C-arms global market is drives by the rapid technological advancement, rapid innovation in production and modeling technologies, increasing privatization in the healthcare sector, rising adoption of refurbished medical devices in emerging countries.However, lack of skilled professional and lack of standardization and harmonization of policies act as a major barriers for this market.C-Arms Devices Market: Segmentation C-arms devices global market is segmented into following types: Mobile C-Arms , Full-Size C-Arms, Mini Size C-Arms, C-Arms Devices Market: Region-wise Outlook, Depending on geographic region, C-arms devices global market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.Due to the increasing awareness about medical imaging equipment, financial stability to purchase expensive devices, adoption of innovative products, and growing infrastructure investment to support medical and healthcare development, North America led the C-arms devices market.
According to the new market research report on the "Metamaterial Market by Material Type (Electromagnetic, Terahertz, Photonic, Tunable, and FSS ), Application (Communication Antenna, Windscreen, Solar Panel, Sensing, Display, and Medical Imaging), Vertical and Geography - Global Forecast to 2025", this market is expected to be valued at USD 4,634.8 Million by 2025, at a CAGR of 63.1% between 2017 and 2025.The major factors driving the growth of the metamaterial market include variety in design functionalities, anti-glare coating applications, and invisibility cloak for stealth aircraft.Communication antenna expected to have the largest market size by 2025Communication antenna accounted for the largest share of the metamaterial market based on application segment in 2016.The growth of this market can be attributed to the usage of antenna for major communication applications such as satellite communication, Wi-Fi routers and radar communication.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139795737The metamaterial market for frequency selective surface to grow at the highest rate during the forecast periodThe metamaterial market for frequency selective surface based on material segment is likely to grow at the highest rate during the forecast period.This is mainly because of the major interest from the defense vertical for this material type, which can be used to create radar covers called radomes.The metamaterial market for the automotive vertical to grow at the highest rate during the forecast periodThe metamaterial market for automotive vertical is expected to grow at the highest rate between 2017 and 2025.This high market growth rate can be attributed to the growing usage of communication antenna applications in the connected cars concept.Americas likely to hold the largest share of the metamaterial market during the forecast periodAmericas is expected to hold the largest share of the metamaterial market during the forecast period.The high growth can be attributed to the increasing demand from the aerospace and defense vertical.
For many decades, scientists have cleverly exploited this selective tagging mechanism in natural antibodies to engineer antibody-based probes that let them purify and study different types of proteins within cells.One tried and true technique, epitope tagging, involves fusing an epitope to a protein of interest and using fluorescently labeled antibodies to make those proteins visible - but only in fixed, dead cells.The work, led by CSU Monfort Professor Tim Stasevich and Tokyo Tech Professor Hiroshi Kimura, is described July 3 in the journal Nature Communications.According to first author Ning Zhao, a postdoctoral researcher in Stasevich's lab who designed most of the experiments, their new antibody-based probe is affectionately called a "frankenbody.""You don't need a tag, like a Green Fluorescent Protein, because instead you have this fluorescent antibody that will bind to your protein that you want to visualize."The new probe would be a useful complement to the green fluorescent protein (GFP), a widespread biochemistry tool and subject of a Nobel Prize that involves genetically fusing a light-up green tag to a protein of interest.
Small Animal Imaging Market Analysis By Reagent (MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents), Modality, Key Players, Regional Analysis, Forecast To 2023Global Small Animal Imaging Market will Grow at 6.5% CAGR during the forecast period 2018 to 2023.Pet Healthcare sector around the world has catapulted the Rising of Small Animal Imaging Market as the pet owners are willing to pay for veterinary care.The adoption rate of small animals has increased over the years which will complement the growth of the market throughout the review period.The pet tracers segment is further segmented into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes.The CT contrast agents segment is sub-segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, and, gold nanoparticles and gastrografin-based small animal CT contrast media.
Global Perfusion Imaging Market Analysis By Applications (Brain imaging, Myocardial Perfusion Imaging, Ventilation Perfusion Imaging), Methods and Key Players, Forecast To 2023Global Perfusion Imaging Market is expected to earn revenues worth USD 12.03 billion while growing at an 8.2 % CAGR in the forecast period.Market reports associated with the healthcare sector made accessible by Market Research Future along with published reports on other sectors have been lately put out along with a report on this industry.The rise in the number of chronic diseases such as brain tumors and cardiac diseases has amplified the progress of the market noticeably.Furthermore, upsurge in the number of geriatric populations will fuel the growth of the market significantly over the forecast period.By methods, the market has been segmented into computed tomography (CT), microspheres, nuclear medicine, magnetic resonance imaging (MRI), and other.
EMBL's European Bioinformatics Institute (EMBL-EBI) is expanding its remit to include bioimaging data.Through its new, dedicated resource for biological images, called the BioImage Archive, EMBL-EBI aims to make it easier for researchers around the world to store, share, access and analyse biological images.Easy access to bioimaging data could offer new insights into how life works at a molecular level and could advance knowledge in fields such as human health and disease, food security and biodiversity.These new data types present many exciting opportunities but also several challenges, including:Sharing - access to and reuse of images is essential for biologists because it improves research quality and significantly speeds up scientific discoveryDiversity - imaging is not a single technology, but an umbrella term for many different methods, scales and resolutions
Hybrid Operating Room Market Report by Share, Size, SWOT analysis, Dynamics, Insights, Future Outlook, Demand, Profile, Trends with North America, Europe, Asia Pacific and the Middle East & Africa Regional Analysis and Key Players NDS Surgical Imaging (US), Mizuho OSI (US), Koninklijke Philips N.V (the Netherlands), STERIS plc.(US), Siemens Healthcare GmbH (Germany), and SISCO Ltd (India), Eschmann Equipment (UK), Cook Medical Inc. (US), General Electric Company (US), Maquet Holding BV & Co. KG (Germany), Johnson & Johnson Services, Inc. (US), Mediflex Surgical Products (US), Forecast To 2023Hybrid Operating Room (Hybrid OR) is an advanced surgical theater that is highly equipped with futuristic medical imaging devices such as fixed C-Arms, and CT/ MRI scanners, and others so as to combine developed imaging capability with a fully functioning operating room.Technical advancements transpired in the healthcare domain across the globe, is acting as a key driving force to escalate Hybrid Operating Room Market growth to furthered heights.Augmenting demand for state of the art operating rooms heading with growing demand for technologically advanced surgical process and an upsurge in the care giving facilities drive the market growth of hybrid operating room.Recognizing the traction the market is vibrating currently with and the potential this market holds to grow further, Market Research Future (MRFR) in its recently published study report asserts that the global Hybrid Operating Room market is expected to evaluate at exponential value by 2023, registering an impressive CAGR of 12.5% over the assessment period (2017 – 2023).Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/862A hybrid operating room has become an integral part of hospitals and clinical setting, providing good outcomes by improving the surgical processes.Burgeoning healthcare sector worldwide, along with the proliferation of care facilities define the growing market landscape of Hybrid OR.Over the last decade, the healthcare industry is growing by leaps and bound due to the ever-increasing population prompting a tremendous need for effective treatment and care.Besides a large number of market players providing technologies and equipment required in a Hybrid OR fosters the market growth across the globe.However, the efficacy that an efficient hybrid OR provides is expected to support the market growth during the assessment period.Browse Full Research Report @ https://www.marketresearchfuture.com/sample_request/862Global Hybrid Operating Room Market - SegmentsMRFR has segmented its analysis into four key dynamics for enhanced understanding.By Techniques : Fluoroscopy and Data Acquisition, Rotational Angiography, and Digital Subtraction Angiography among others.By Applications : Cardiovascular Surgery, Neurosurgery, Thoracic Surgery, and Endo-Bronchial Procedures among others.By End-Users : Hospitals, Clinics, and Medical Research Firms, among others.By Regions : Europe, North America, APAC and the Rest-of-the-World.Global Hybrid Operating Room Market – Geographical AnalysisGlobally, the North American region is dominating the global Hybrid OS market owing to substantial investments transpired into R activities in healthcare.
BEER-SHEVA, ISRAEL...July 2, 2019 - Ben-Gurion University of the Negev (BGU) announces that it is pursuing joint research and development programs to advance quantum technology together with the Israel Ministry of Defense, the U.S. Air Force and the U.S. Navy, as well as the high-tech industry in Israel and around the world.Quantum technology leverages 100-year-old quantum theory developed into specific applications, such as high-precision atomic clocks; gravitational and magnetic sensors; and navigation systems, as well secure communication systems and quantum computers, expected to outperform traditional computers.Ben-Gurion University has unique and advanced expertise in this fast-emerging field and is establishing research relationships with different defense organizations as well as the high-tech industry such as Accubeat Ltd. BGU researchers have already delivered several prototypes of various technologies to these companies and defense organizations.This may include drug engineering, medical imaging (e.g.of the brain), privacy, water and mineral detection, as well as an improved electrical grid."Quantum theory includes a very strange set of rules and its quirkiness will result in revolutionary quantum technology with vastly different capabilities than what we are used to," according to Prof. Ron Folman, the Ruth Flinkman-Marandy and Ben Marandy Chair in Quantum Physics and Nanotechnology, head of the BGU Atom Chip Laboratory.
When it comes to driving down the cost of wind energy, one simple way of avoiding unnecessary expenditure is to regularly check the blades of wind turbines for damage.By spotting signs of damage early, blades can be kept in service for longer before needing replacement.Unfortunately, that’s a task that’s easier said than done using traditional inspection methods, such as ground-based surveying.Fortunately, researchers at Sandia National Laboratories have another solution — and it involves a combination of blade-crawling robots and flying inspection drones.While doing this, they use on-board cameras to capture high-fidelity images of the blades, in addition to performing special ultrasonic imaging.This provides unique signatures for each blade which can be analyzed to indicate damage.
The global healthcare information systems market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors.The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times.Global Healthcare Information Systems Market: Competitive LandscapeSome of the key players in the global healthcare information systems market areAgfa-Gevaert N.V.Allscripts Healthcare Solutions Inc.Athenahealth Inc.Carestream HealthCerner CorporationGE HealthcareMcKesson CorporationMedidata Solutions Inc.NextGen HealthcarePhilips HealthcareSiemens HealthineersHealthcare Information Systems Market SegmentationThe global healthcare information systems market is segmented based on type, components, deployment, end user, and region.On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management.The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others.On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.Healthcare Information Systems Market Regional AnalysisThe Americas leads the global healthcare information systems market.Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.
In 2019, the Market size of Contrast Media/Contrast Agents market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Contrast Media/Contrast Agents market.Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of Contrast Media/Contrast Agents market Report This report studies the global market size of Contrast Media/Contrast Agents market, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).This study presents the Contrast Media/Contrast Agents market production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications.history breakdown data from 2014 to 2019, and forecast to 2025.For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.In global market, the following companies are covered:GE HealthcareBayer AGBracco Imaging S.P.A.Guerbet GroupLantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)Nanopet Pharma GmbHCMC Contrast ABDaiichi SankyoSubhra Pharma Private LimitedSpago Nanomedical ABMarket Segment by Product Type IodinatedGadoliniumBariumMicrobubbleMarket Segment by Application RadiologyInterventional RadiologyInterventional CardiologyKey Regions split in this report: breakdown data for each region.United StatesChinaEuropean UnionRest of World (Japan, Korea, India and Southeast Asia)The study objectives are: To analyze and research the Contrast Media/Contrast Agents market status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.To present the key Contrast Media/Contrast Agents market manufacturers, presenting the sales, revenue, market share, and recent development for key players.To split the breakdown data by regions, type, companies and applicationsTo analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends, drivers, influence factors in global and regionsTo analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the marketIn this study, the years considered to estimate the market size of Contrast Media/Contrast Agents market are as follows: History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025 Get the Complete Report & TOC of Contrast Media/Contrast Agents market CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170Email: email@example.comFollow Us On linkedin :- https://www.linkedin.com/company/24-market-reports